Stage 1 Financial Revenue and Competitors
Estimated Revenue & Valuation
- Stage 1 Financial's estimated annual revenue is currently $12.9M per year.
- Stage 1 Financial's estimated revenue per employee is $189,000
Employee Data
- Stage 1 Financial has 68 Employees.
- Stage 1 Financial grew their employee count by -11% last year.
Stage 1 Financial's People
| Name | Title | Email/Phone |
|---|---|---|
1 | Co-Founder | Reveal Email/Phone |
2 | Controller | Reveal Email/Phone |
3 | VP Accounting | Reveal Email/Phone |
4 | Head Onboarding | Reveal Email/Phone |
5 | Controller | Reveal Email/Phone |
6 | Director Sales | Reveal Email/Phone |
7 | Marketing Manager | Reveal Email/Phone |
8 | State And Local Tax Manager | Reveal Email/Phone |
9 | Financial Planning and Analysis Manager | Reveal Email/Phone |
10 | Business Intelligence Manager | Reveal Email/Phone |
Stage 1 Financial Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $6.9M | 41 | -5% | N/A | N/A |
#2 | $42M | 182 | 1% | N/A | N/A |
#3 | $27.7M | 132 | -3% | N/A | N/A |
#4 | $6.4M | 38 | 3% | N/A | N/A |
#5 | $25.2M | 120 | 5% | N/A | N/A |
#6 | $36M | 156 | 8% | N/A | N/A |
#7 | $299.3M | 1018 | 37% | N/A | N/A |
#8 | $3.2M | 22 | 16% | N/A | N/A |
#9 | $5.4M | 32 | 3% | N/A | N/A |
#10 | $16.6M | 79 | N/A | N/A | N/A |
What Is Stage 1 Financial?
Young, fast growing companies face many challenges, one being how to manage the financial and strategic needs for a CFO and accounting department. Stage 1 Financial meets this challenge by delivering a fully outsourced finance and accounting solution which aligns with our clients organizational and strategic priorities.
keywords:N/A
N/A
Total Funding
68
Number of Employees
$12.9M
Revenue (est)
-11%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Stage 1 Financial News
as well as its 2022 financial calendar ... The Company is also pursuing a Phase 1 investigator-sponsored clinical trial in first-line...
Report topline results from Part B of the Phase 1 study of ALN-HSD in patients with NASH. Financial Results for the Quarter Ended March 31, 2022.
We expect to report the initial results from a Phase 1 trial of this compound later in the year. During the quarter, we also continued...
Other Companies in Anaheim
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | N/A | 68 | -4% | N/A |
#2 | $14M | 68 | -1% | N/A |
#3 | $9.2M | 68 | -7% | N/A |
#4 | $16.5M | 68 | 6% | N/A |
#5 | $15.5M | 68 | -6% | N/A |